Insiders · Profile

TRABER PETER G

Chief Medical Officer at Cartesian Therapeutics · President & CEO at GALECTIN THERAPEUTICS. Filing since 8 Oct 2012. CIK 0001284500

Company
Date
Role
Action
Shares
Amount
Of holding
25 Sep 2023
Chief Medical Officer
Sold at will
705
$747.30
0.2%
5 Jan 2023
Chief Medical Officer
Sold, plan not stated
3,465
$3.91K
0.8%
4 Jan 2023
Chief Medical Officer
Sold, plan not stated
8,179
$9.27K
1.8%
5 Jan 2022
Chief Medical Officer
Sold, plan not stated
3,226
$9.96K
1.3%
10 Dec 2021
Chief Medical Officer
Sold, plan not stated
4,083
$12.20K
2.4%
13 Oct 2021
Chief Medical Officer
Sold, plan not stated
3,636
$15.96K
2.3%
26 May 2021
Chief Medical Officer
Bought
20,000
$79.85K
17.3%
25 May 2021
Chief Medical Officer
Bought
5,000
$17.40K
4.5%
24 May 2021
Chief Medical Officer
Bought
12,500
$41.50K
12.8%
18 Mar 2021
Chief Medical Officer
Bought
10,000
$45.00K
11.4%
17 Mar 2021
Chief Medical Officer
Bought
10,000
$45.30K
12.8%
14 Dec 2020
Chief Medical Officer
Bought
40,000
$129.42K
opened
13 Jun 2018
President & CEO
Sold, plan not stated
100,000
$751.00K
48.2%
8 Jun 2018
President & CEO
Sold, plan not stated
70,000
$410.00K
39.5%
12 Aug 2015
President & CEO
Bought
2,000
$4.00K
1.9%
1 Jun 2015
President & CEO
Bought
4,000
$10.12K
3.9%
14 Aug 2014
President and CEO
Bought
4,000
$17.84K
4.1%
13 Aug 2014
President and CEO
Bought
1,000
$4.42K
1.0%
9 Dec 2013
President and CEO
Bought
500
$4.45K
0.5%
5 Dec 2013
President and CEO
Bought
500
$4.50K
0.5%
19 Nov 2013
President and CEO
Bought
1,000
$5.53K
1.1%
18 Nov 2013
President and CEO
Bought
1,000
$5.80K
0.2%
12 Oct 2012
President and CEO
Bought
2,500
$5.29K
0.5%
9 Oct 2012
President and CEO
Bought
2,500
$5.00K
0.5%
8 Oct 2012
President and CEO
Bought
5,000
$10.35K
1.0%
25 decisions on file.